Clinical Trials Logo

Clinical Trial Details — Status: Recruiting

Administrative data

NCT number NCT04488341
Other study ID # P.T.REC/012/002676
Secondary ID
Status Recruiting
Phase N/A
First received
Last updated
Start date September 20, 2020
Est. completion date August 20, 2022

Study information

Verified date August 2021
Source Cairo University
Contact Hany FM Elsisi, phd
Phone 00966580239275
Email Elsisihany309@gmail.com
Is FDA regulated No
Health authority
Study type Interventional

Clinical Trial Summary

PURPOSE: to determine the effect of aerobic exercise training on sex hormones and coagulation factors in postmenopausal elderly women BACKGROUND: Cardiovascular disease (CVD) is the largest cause of death in women, and the risk of developing CVD increases after menopause . Because thrombosis is thought to be a cause of most acute cardiovascular events, abnormalities in endogenous coagulation and fibrinolysis may play an important role in the risk of an acute cardiovascular event. Aging is also associated with adverse changes in both coagulation and fibrinolysis. For instance, postmenopausal women exhibit higher fibrinogen levels and lower levels of endogenous fibrinolysis. Physical activity and physical fitness have consistently been linked to lower CVD rates in women. In fact, an inverse association between physical activity and total mortality, as well as a 50% reduction in risk of myocardial infarction, has been observed in physically active postmenopausal women. In addition to the numerous other benefits provided by regular physical activity, one of the mechanisms mediating the cardioprotective effect may be changes in the hemostatic system, particularly fibrinolysis HYPOTHESES: Aerobic exercises may have no effect on sex hormones and coagulation factors in elderly postmenopausal women RESEARCH QUESTION: Do aerobic exercises effect on sex hormones and coagulation factors in elderly postmenopausal women in response to exercises?


Description:

It is an interventional study in which 40 women estimated to enroll according to random allocation and assigned into two groups equally. The study group will receive aerobic exercises in addition to diet recommendations while the control group will receive diet recommendations. the aerobic exercises time of session 40-50 min initial 10 min warm up exercises on treadmill in low intensity and active phase 20- 30 min intensity will increase until patient reach to target heart rate then intensity decrease until session will be ended by cooling down phase for 10 min . The volunteers will perform exercises 3 times per week for 12 weeks .coagulation factors(Prothrombin time, Partial Thromboplastin Time , plasminogen activator inhibitor-1 , fibrinogen and tissue plasminogen activator )will be measured and sex hormones (estradiol ,testosterone. sex hormone binding globin ) pre and post intervention


Recruitment information / eligibility

Status Recruiting
Enrollment 40
Est. completion date August 20, 2022
Est. primary completion date May 15, 2022
Accepts healthy volunteers No
Gender Female
Age group 60 Years to 70 Years
Eligibility Inclusion Criteria: - • forty Postmenopausal women (60-70 y) - Body mass index (BMI) ranged from 35 to 39.9 kg/m2 Exclusion Criteria: - • regular medications(e.g., ß-blockers, a-blockers, digoxin, diuretics, aspirin, nitrates, Presently using hormone replacement therapy (HRT) and non steroidal anti-inflammatory drugs, - smoking; - cognitive impairment that will make it difficult to partake in the study - presence of malignant disease - blood donation within the last 6 months - Participation as a subject in any type of study or research during the prior 90 days - hypertension, - having active chronic illness (e.g., rheumatoid arthritis, hyperthyroidism, and inflammatory bowel disease) and diabetes mellitus or other (unstable) endocrine-related diseases - personal history of cardiovascular diseases, - Orthopedic problems inhibiting exercises.

Study Design


Intervention

Other:
aerobic exercises in addition to diet recommendations
aerobic exercises time of session 40-50 min initial 10 min warm up exercises on treadmill in low intensity and active phase 20- 30 min intensity will increase until patient reach to target heart rate then intensity decrease until session will be ended by cooling down phase for 10 min . The volunteers will perform exercises 3 times per week for 12 weeks
diet recommendations
control group will receive diet recommendations for 12 weeks

Locations

Country Name City State
Egypt Physical Therapy Cairo

Sponsors (1)

Lead Sponsor Collaborator
Cairo University

Country where clinical trial is conducted

Egypt, 

Outcome

Type Measure Description Time frame Safety issue
Primary coagulation factors change of selected coagulation factors by blood analysis (plasminogen activator inhibitor-1 ,tissue plasminogen activator ,Prothrombin time ,Partial Thromboplastin time ,fibrinogen ) 12 weeks
Primary sex hormones change of (estradiol ,testosterone. sex hormone binding globin ) 12 weeks
Secondary weight measuring weight in kilograms 12 weeks
Secondary height measuring height in meters 12 weeks
See also
  Status Clinical Trial Phase
Completed NCT03826043 - THrombo-Embolic Event in Onco-hematology N/A
Recruiting NCT04274777 - The Relationship Between Lipid Peroxidation Products From Traumatic Brain Injury and Secondary Coagulation Disorders
Recruiting NCT03136510 - Evolution of Coagulation Activity in Non Valvular Atrial Fibrillation Patients Under Apixaban N/A
Completed NCT01588132 - Anfibatide Phase 1 Clinical Trial in Healthy Volunteers Phase 1
Recruiting NCT04524637 - The Utility of Thromboelastography in Traumatic Brain Injury
Completed NCT03634215 - Estimation of Coagulation Factor XIII Activity Based on the Initial Plasma Fibrinogen Level in Trauma
Completed NCT05152420 - Study of Intravenous VMX-C001 in Healthy Subjects and in Combination With Selected Direct Oral Anticoagulants in Healthy Older Subjects Phase 1
Recruiting NCT05645081 - Extracellular Vesicles and Dysregulated Coagulation in the Prediction of Stroke
Completed NCT04322721 - Coagulopathy on the First Postoperative Day Predicts the Long-term Survival of Traumatic Brain Injury Patients
Completed NCT03267823 - INR Comparison Testing in Cardiac Surgery
Completed NCT04490759 - QStat Pilot Reference Range Study
Completed NCT04107818 - Comparison of Viscoelastic Measurement by ROTEM® Delta and ClotPro® in Trauma Patients.
Recruiting NCT05484830 - Coagulation in Acute Aortic Dissection N/A
Recruiting NCT04111120 - Heparin Like Effect in Acute Variceal Bleeding
Completed NCT05162339 - Inflammatory Bowel Disease and Thromboembolic Events
Completed NCT03555630 - Thromboelastogram in Postdelivery Preeclamptic Patients
Completed NCT01589172 - Evaluating the Use of Thromboelastography to Diagnose Coagulopathy After Traumatic Brain Injury
Recruiting NCT04278404 - Pharmacokinetics, Pharmacodynamics, and Safety Profile of Understudied Drugs Administered to Children Per Standard of Care (POPS)
Completed NCT03956836 - Perioperative Coagulopathy in Patients Undergoing Cytoreductive Surgery and HIPEC Intraperitoneal Chemotherapy (HIPEC)
Completed NCT06154018 - Heparin Reversal With Two Different Protamine Ratios After Cardiopulmonary By-pass. N/A